Rapport Therapeutics, Inc. (NASDAQ:RAPP) is among the best fast money stocks to buy now. Analysts at JMP Securities have reaffirmed their ‘Market Outperform’ rating on Rapport Therapeutics, Inc.
Investing.com - JMP Securities has reiterated its Market Outperform rating and $18.00 price target on Larimar Therapeutics (NASDAQ:LRMR), following a 34% drop in the company’s stock price on Monday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback